Pneumocystis carinii pneumonia occurs almost exclusively in the immunocompromised host. Isolated P. carinii organisms have been identified, however, in the lungs of individuals with no evidence of disease. ' It is thought that clinical infection occurs as a result of reactivation of latent organisms producing replication and subsequent disease. There have been problems encountered in the development of specific methods for detecting infection histologically and serologically and these have caused the reliability of serological diagnosis in particular by either complement fixation or indirect immunofluorescence to be questioned.
Previous studies have suggested that there is a high prevalence of latent infection, with almost 100% of normal children tested in a Dutch study having positive antibody by the age of 2.2 A similar study carried out by Pifer et al found that by the age of 4 years two thirds of normal children had antibody to P. carinii in titres of 1:16 or greater.3
Both of these authors concluded that their results indicated subclinical infection was highly prevalent in normal children but that disease was manifested in the compromised host only.
As part of a prospective study of pneumocystis antibody titres in children with acute lymphoblastic leukaemia we wished to find whether these observations applied to non-immunosuppressed children in the United Kingdom.
Patients and methods
Serum samples from 145 children were studied. Specimens were obtained at the same time as other routine blood tests from children attending the diabetic clinic at the Royal Victoria Infirmary, Newcastle (50 children), and from children attending the paediatric outpatient clinics at the Royal Hospital for Sick Children, Edinburgh (95 children). The latter group comprised children attending the cardiology and haematology departments. No child was known to be suffering from any immunosuppressive illness and none was on steroid medication. The age range was 0-45 to 13-9 years (mean 7-4 years and median 7*35 years). There were 82 boys and 63 girls in the study.
Serum samples were tested at the microbiology department of the Royal Marsden Hospital, London, using an indirect immunofluorescence test, full details of which have been reported previously. 4 Briefly, the substrate used was a paraffin section of human lung heavily infested with pneumocysts. The tissue was fixed in Bouin's fluid to destroy existing immunoglobulin in the alveolar exudate and to preserve polysaccharide antigen. The Figure. There was a trend to more of the older children having higher levels of antibody but this did not achieve significance. The incidence of P. carinii pneumonitis is difficult to ascertain. A study from the USA by Siegel et al found an incidence of P. carinii pneumonia of 6-8% in a group of 844 children undergoing treatment for acute lymphoblastic leukaemia.7 Darbyshire et al in a report from the UK documented an incidence of proven P. carinii pneumonitis of 9% in a group of 199 children with acute lymphoblastic leukaemia.8 Thus it would seem that there is no great difference in the incidence of pneumonitis due to pneumocystis in the immunocompromised children from the USA and UK despite the different distribution of antibody titres in the population.
All three studies used an indirect immunofluorescence method for the detection of antibodies. This study used human lung heavily infested with pneumocysts. The 
